Kenneth Baillie
Chief Investigator at GenOMICC Consortium. Baillie is also member of the Division of Genetics and Genomics at the Roslin Institute in Scotland.
Chief Investigator of the 'GenOMICC study on COVID-19 patients' project.
This study aims to find out whether there are genetic factors that mean that some people experience severe symptoms whilst others experience only mild symptoms.
Kenneth's research interest is the genetics of host susceptibility to severe infection. He led the GenISIS (Genetics of Influenza Susceptibility in Scotland) study and the host genetics component of the MOSAIC (Mechanisms of Severe Influenza Consortium) study. In his role as working group chair for genomics, pathogenesis and pharmacology for the International Severe Acute Respiratory Infection Consortium (ISARIC), he led the development of an integrated biological sampling protocol for use in outbreaks, which is supported by the World Health Organization and has been adopted in many countries throughout the world.
Chief Investigator of the 'GenOMICC study on COVID-19 patients' project.
This study aims to find out whether there are genetic factors that mean that some people experience severe symptoms whilst others experience only mild symptoms.
Kenneth's research interest is the genetics of host susceptibility to severe infection. He led the GenISIS (Genetics of Influenza Susceptibility in Scotland) study and the host genetics component of the MOSAIC (Mechanisms of Severe Influenza Consortium) study. In his role as working group chair for genomics, pathogenesis and pharmacology for the International Severe Acute Respiratory Infection Consortium (ISARIC), he led the development of an integrated biological sampling protocol for use in outbreaks, which is supported by the World Health Organization and has been adopted in many countries throughout the world.
Country:
UK